Company Filing History:
1 out of 1,595 
1 out of 1,650 
Years Active: 2025
Title: Eric S. Sorensen: Innovator in Immune Cell Therapy
Introduction
Eric S. Sorensen is a notable inventor based in Washington, DC, recognized for his contributions to the field of immune cell therapy. With a focus on enhancing immune responses, Sorensen has developed innovative methods that have the potential to transform therapeutic approaches in immunology.
Latest Patents
Sorensen holds a patent titled "Targeting STAT sumoylation to enhance immune responses." This patent relates to compositions and methods for the ex vivo expansion of immune cells isolated from a subject. The technology allows for the modulation of gene expression to enhance immune cell activity in the resulting expanded immune cell culture. This advancement enables the creation of immune cell therapies that contain genetically modified immune cells suitable for adoptive cell transfer into subjects in need.
Career Highlights
Throughout his career, Eric S. Sorensen has worked with prestigious institutions, including Washington University and the University of Utah Research Foundation. His work has significantly contributed to the understanding and application of immune cell therapies.
Collaborations
Some of his notable coworkers include Alberto Bosque-Pardos and Amanda Beatriz Rodrigues Barreto De Macedo. Their collaborative efforts have furthered research in the field of immunology and enhanced the development of innovative therapies.
Conclusion
Eric S. Sorensen's work in immune cell therapy exemplifies the impact of innovative thinking in medicine. His patent and collaborations highlight the importance of advancing therapeutic techniques to improve patient outcomes.